Pulmonx (LUNG)
Builds bronchoscopic emphysema treatments around Zephyr valves and patient-selection tools.
$2.05
Pre-market−0.24 (−10.47%)
At close$2.29(+2.23%)
Something off on this page? Send us feedback.
Next report
Nov 11, 2026
in 69 days
EPS estimate
−$0.26
Revenue estimate
$21.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Nov '25Mar '26Apr '26Jul '26Nov '26
Reported−$0.33−$0.36−$0.38−$0.34−$0.25−$0.33−$0.24Pending
Estimate−$0.45−$0.37−$0.40−$0.40−$0.39−$0.33−$0.28−$0.26
Surprise+26.7%+2.7%+5.0%+15.0%+35.9%0.0%+14.3%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Nov '25Mar '26Apr '26Jul '26Nov '26
Reported$23.8M$22.5M$23.9M$21.5M$22.6M$20.6M$22.8MPending
Estimate$22.3M$22.0M$23.4M$21.7M$21.7M$20.4M$22.4M$21.9M
Surprise+6.6%+2.3%+2.0%−1.0%+4.0%+0.8%+1.6%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.26 | — | — |
| Jul 2026 | −$0.28 | −$0.24 | +14.3% |
| Apr 2026 | −$0.33 | −$0.33 | 0.0% |
| Mar 2026 | −$0.39 | −$0.25 | +35.9% |
| Nov 2025 | −$0.40 | −$0.34 | +15.0% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Jan 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.26 | — | — | $21.9M | — | — | — |
| Jul 29, 2026 | −$0.28 | −$0.24 | +14.3% | $22.4M | $22.8M | +1.6% | +28.8% |
| Apr 29, 2026 | −$0.33 | −$0.33 | 0.0% | $20.4M | $20.6M | +0.8% | +6.7% |
| Mar 4, 2026 | −$0.39 | −$0.25 | +35.9% | $21.7M | $22.6M | +4.0% | +11.8% |
| Nov 12, 2025 | −$0.40 | −$0.34 | +15.0% | $21.7M | $21.5M | −1.0% | −18.9% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||||||
| Jul 30, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Feb 19, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Oct 30, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 2, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 23, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 3, 2021 | |||||||
| May 4, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Sep 4, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Jan 28, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||